Eton Pharmaceuticals Q1 2024 GAAP EPS $(0.03) Beats $(0.07) Estimate, Sales $7.966M Miss $8.000M Estimate

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.07) by 57.14 percent. This is a 70 percent increase over losses of $(

BenzingaMay 10 05:05

Eton Pharmaceutical | 10-Q: Quarterly report

Futu NewsMay 10 04:29 · Announcements

Eton Pharmaceuticals Expects Continued Sales Growth to Result in Positive Operating Cash Flow Throughout 2024 >ETON

Eton Pharmaceuticals Expects Continued Sales Growth to Result in Positive Operating Cash Flow Throughout 2024 >ETON

Dow JonesMay 10 04:29

Earnings Flash (ETON) ETON PHARMACEUTICALS Posts Q1 Revenue $8M, Vs. Street Est of $8M

04:06 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (ETON) ETON PHARMACEUTICALS Posts Q1 Revenue $8M, vs. Street Est of $8M

MT NewswiresMay 10 04:06

Press Release: Eton Pharmaceuticals Reports First Quarter 2024 Financial Results

Eton Pharmaceuticals Reports First Quarter 2024 Financial Results -- Q1 2024 revenue of $8.0 million, representing 50% growth over Q1 2023 and the 13(th) straight quarter of sequential product sales

Dow JonesMay 10 04:01

Eton Pharmaceuticals 1Q Loss/Shr 3c >ETON

Eton Pharmaceuticals 1Q Loss/Shr 3c >ETON

Dow JonesMay 10 04:01